Sorafenib HCC Assessment

Related by string. * sorafenib : Nexavar sorafenib tablets . sorafenib Nexavar R . sunitinib sorafenib . sorafenib Nexavar / HCCS . HCCs : DF HCC designated . DF HCC . unresectable hepatocellular carcinoma HCC . hepatocellular carcinoma HCC / assessments . assessment . Assessments : Florida Comprehensive Assessment . Special Protocol Assessment . Massachusetts Comprehensive Assessment * *

Related by context. Frequent words. (Click for all words.) 68 Phase III randomized 67 multicenter clinical 67 multicentre 66 placebo controlled randomized 66 phase IIa 65 multicenter randomized double 65 placebo controlled clinical 65 dose escalation trial 64 multicenter randomized 64 randomized controlled clinical 64 randomized Phase III 63 prospective observational 63 Phase 1b clinical 63 prospective randomized controlled 63 randomized placebo controlled 62 Phase 2a clinical 62 multicenter 62 EORTC 62 Phase 2b study 61 TRITON TIMI 61 placebo controlled 61 Phase 2b clinical 60 SPIRIT III 60 phase IIb 60 active comparator 60 axitinib 60 randomized controlled clinical trials 60 Phase III pivotal 60 randomized controlled 60 blind randomized 60 randomized double 60 prospective randomized 59 multicenter study 59 randomized Phase 59 Phase 2b 59 Phase 1b trial 59 blinded placebo controlled 59 randomized clinical 59 Phase III clinical 59 blind randomized placebo 59 substudy 59 Phase IIb clinical 59 Phase 1b 58 blind randomized controlled 58 tocilizumab 58 SCH # 58 phase 2a 58 Phase IIa clinical 58 Phase 2a trial 58 nab paclitaxel 58 Phase Ib 58 double blinded placebo 58 Phase III Trial 58 metastatic renal cell carcinoma 58 pivotal Phase 58 Clinical Trial Results 57 Phase IIa trial 57 relapsed refractory multiple myeloma 57 Phase 2b trial 57 Myocardial Infarction 57 clinical trial 57 confirmatory Phase III 57 HER2 positive metastatic breast 57 TYKERB 57 blind placebo controlled 57 LIALDA 57 Phase 1a 57 ATTRACT 57 mg QD 57 Taxotere ® 57 pivotal Phase III 57 plus prednisone 57 Randomized 56 peginterferon alfa 2b 56 double blind placebo 56 Phase IIb 56 PF # [001] 56 mg BID 56 neoadjuvant 56 Phase Ia 56 darapladib 56 League Against Rheumatism 56 placebo controlled trials 56 CAPRISA 56 Chronic Hepatitis C 56 dabigatran etexilate 56 Solid Tumors 56 BLA submission 56 IIa clinical trial 56 TORISEL 56 diabetic neuropathic pain 55 tesmilifene 55 sunitinib 55 multiple ascending dose 55 RTOG 55 Cooperative Oncology 55 Phase III 55 temsirolimus 55 LymphoStat B 55 lacosamide 55 aflibercept

Back to home page